Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia

Journal of Hepatology

Volumn 44, Issue 2, 2006, Pages 407-410

  De Bruyne, Ruth ^a   Portmann, Bernard ^a   Samyn, Marianne ^a   Bansal, Sanjay ^a   Knisely, Alex ^a   Mieli Vergani, Giorgina ^a   Dhawan, Anil ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

6 Thioguanine; Acute lymphoblastic leukaemia; Children; Hepatic toxicity; Nodular regenerative hyperplasia; Portal hypertension; UK ALL 97 99 clinical trial

Indexed keywords

MERCAPTOPURINE; TIOGUANINE;

ACUTE LYMPHOCYTIC LEUKEMIA; CHRONIC LIVER DISEASE; ECHOGRAPHY; HEPATOMEGALY; HUMAN; LIVER BIOPSY; LIVER CELL; LIVER TOXICITY; MICROSCOPY; NODULAR HYPERPLASIA; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT DURATION; UNITED KINGDOM; VEIN DISEASE;

EID: 30344466643     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.06.020     Document Type: Article

References (15)

1. Medical Research Council Working Party on Leukaemia in Children UK National Lymphoblastic Leukaemia (ALL) Trial. MRC ALL 97/99 Protocol.
2. Report from Childhood Leukaemia Working Party NCRI Annual Review May 2003.
3. S. Stoneham, L. Lennard, P. Coen, J. Lilleyman, and V. Saha Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia Br J Haematol 123 2003 100 102
4. J.H. Burchenal, M.L. Murphy, and R.R. Ellison Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukaemia and allied diseases Blood 8 1953 965 998
5. L. Lennard, H.A. Davies, and J.S. Lilleyman Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia? Br J Cancer 68 1993 186 190
6. L. Lennard, J.S. Lilleyman, J. van Loon, and R.M. Weinshilboum Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia Lancet 336 1990 225 229
7. P.F. Griner, A. Elbadawi, and C.H. Packman Veno-occlusive disease of the liver after chemotherapy of acute leukaemia: report of two cases Ann Int Med 85 1976 578 582
8. N.L. Kao, and H.J. Rosenblate 6-thioguanine therapy for psoriasis causing toxic hepatic Veno-occlusive disease J Am Acad Dermatol 28 1993 1017 1018
9. P.C.A. Shepherd, J. Fooks, R. Gray, and N.C. Allan Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension Br J Haematol 79 1991 185 192
10. N. Haboubi, H. Ali, H. Whitwell, and P. Ackrill Role of endothelial cell injury in the spectrum of azathiprine-induced liver disease after transplant: light microscopy and ultrastructural observations Am J Gastroenterol 83 1988 256 261
11. I.R. Wanless Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular nodules Hepatology 11 1990 787 797
12. E.J. Wills Ground glasslike hepatocytes produced by glycogen-membrane complexes ('glycogen bodies') Ultrasctruct Pathol 16 1992 491 503
13. B. Piel, S. Vaidya, D. Lancaster, M. Taj, and K. Pritchard-Jones Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia (letter) Br J Haematol 125 2004 410 411
14. M.C. Dubinsky, E.A. Vasiliauskas, H. Singh, M.T. Abreu, K.A. Papadakis, and T. Tran 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients Gastroenterology 125 2003 298 303
15. E. Gane, B. Portmann, R. Saxena, P. Wong, J. Ramage, and R. Williams Nodular regenerative hyperplasia of the liver graft after liver transplantation Hepatology 21 1994 88 94